US Earnings Financial Results SEC Filings — June 17, 2026

17-06-2026

Somitos Corp. filed its 10-K annual report for the fiscal year ended May 31, 2026, reporting its first-ever revenues of $8,442 but a significantly widened net loss of ($72,693) compared to ($6,215) in the prior period. Cash and cash equivalents increased substantially to $45,167 from $4,589, financed largely through related-party loans and additional paid-in capital. However, the company remains in a stockholders' deficit of ($31,408), with accumulated deficit growing to ($78,908) and total liabilities more than double total assets.

• · The company was incorporated on March 5, 2025, making this only its second reporting period.
• · Intangible assets, net decreased from $42,000 to $33,600, reflecting $8,400 in amortization expenses.
• · Related party loan increased from $46,504 to $51,717, providing $5,213 in financing during FY2026.
• · Deferred revenue of $16,458 was recognized for the first time in FY2026, indicating prepayments from customers.
• · No income tax expense was recorded in either period due to full valuation allowance against deferred tax assets.
• · Net loss per share (basic and diluted) was ($0.00) for both periods due to rounding.
• · The company qualifies as an Emerging Growth Company under the JOBS Act, with annual revenues below $1.07 billion and less than $700 million public float.

17-06-2026

17-06-2026

Smith & Wesson Brands, Inc. (SWBI) filed its 10-K for fiscal year 2026, reporting a 10.4% YoY increase in net sales to $523.8M, driven by an 18.8% surge in handgun sales ($394.4M). Net income jumped 37.7% to $18.5M. However, long-gun sales continued to decline, falling 13.0% to $90.5M, and gross margin remained essentially flat at 26.9%, well below the 29.5% achieved in FY2024. Operating income grew 22.3% to $29.2M but was still significantly lower than the $47.1M reported two years ago.

• · Interest expense increased 4.1% YoY to $4.8M, up from $4.6M in FY2025 and $2.1M in FY2024.
• · Income tax expense rose 13.2% to $6.6M, but the effective tax rate fell from 30.2% to 26.3%.
• · Cash flow from operations swung sharply positive to $114.2M from negative $7.2M in FY2025.
• · The company has a Second Amended and Restated Credit Agreement with TD Bank, N.A. dated October 3, 2024, and a First Amendment to that agreement dated August 15, 2025.
• · The Registrant has an Employment Agreement (and amended version) with Mark P. Smith.
• · Several agreements with American Outdoor Brands, Inc. remain in effect (Transition Services, Tax Matters, Employee Matters, Trademark License).
• · A Project Agreement exists with The Industrial Development Board of Blount County, Tennessee.

17-06-2026

Odyssey Therapeutics reported a net loss of $38.3M for Q1 2026, slightly improved from a $38.4M loss in Q1 2025, as operating expenses decreased 3.2% to $39.8M. However, the company had zero collaboration revenue in Q1 2026 versus $1.9M in the prior-year period, and cash and cash equivalents declined 14.3% to $35.7M from $41.7M at year-end 2025, reflecting continued cash burn.

• · Net loss per share improved to ($6.77) in Q1 2026 from ($39.37) in Q1 2025, driven by a significant increase in weighted-average shares outstanding (5.66M vs 0.98M).
• · Cash used in operating activities increased 6.2% to $41.0M in Q1 2026 from $38.6M in Q1 2025.
• · Total cash, cash equivalents, and restricted cash decreased to $39.2M at March 31, 2026 from $44.9M at December 31, 2025.
• · The company had no long-term marketable securities at March 31, 2026, compared to $35.2M at December 31, 2025.
• · Stock-based compensation expense was $2.6M in Q1 2026, down from $3.0M in Q1 2025.
• · Goodwill decreased 1.8% to $14.1M due to foreign currency translation.
• · Intangible asset, net decreased 38.9% to $0.2M due to amortization and foreign currency translation.
• · Contingent consideration and warrant liability increased slightly to $6.2M from $6.1M.
• · Deferred offering costs of $1.6M were included in accounts payable and accrued expenses as of March 31, 2026.

17-06-2026

Skkynet Cloud Systems reported mixed results for the six months ended April 30, 2026. Revenue declined 18.3% YoY to $1,155,499, driven by a 25.7% drop in product sales, though support revenue grew 5.1%. The company swung to a net loss of $335,901 from a net income of $1,340 in the prior-year period, with operating expenses rising 16.4% and cash used in operations of $280,443 versus cash provided of $100,616. However, the company secured a $166,773 long-term loan and reported a tax refund of $146,232, partially offsetting the operating loss.

• · Operating loss for the three months ended April 30, 2026 was $269,896, compared to a loss of $194,693 in the same quarter last year, a 38.6% increase in operating loss.
• · Accounts receivable increased 53.8% to $579,612 as of April 30, 2026 from $376,830 at October 31, 2025.
• · Deferred revenue rose 37.1% to $476,797 from $347,686, indicating potential future revenue.
• · The company recorded a $166,773 loan payable during the six-month period, which was not present at October 31, 2025.
• · Stock-based compensation expense increased 129.7% to $125,456 for the six months ended April 30, 2026 from $54,637 in the prior-year period.
• · The company's accumulated deficit grew 5.3% to $6,789,287 from $6,447,576 at October 31, 2025.
• · Cash used in operations was $280,443 for the six months ended April 30, 2026, compared to cash provided by operations of $100,616 in the prior-year period.
• · The company received an income tax refund of $146,232 for the six months ended April 30, 2026, versus a tax expense of $1,240 in the prior-year period.

17-06-2026

Kindcard, Inc. reported a net loss of $62,418 for the quarter ended April 30, 2026, compared to a net loss of $55,064 in the same prior-year period, reflecting a widening loss. Revenue declined 13.3% to $74,175 from $85,591, primarily driven by the elimination of Cash Pickup Commission Revenue and a decrease in Tendercard Program Revenue. Cash flow from operations improved, using $21,554 versus $36,809 in the prior year, but the company's total liabilities ($1,240,775) significantly exceed total assets ($60,148), resulting in a deepened stockholders' deficit of ($1,180,627).

• · Cash decreased from $9,160 (Jan 31, 2026) to $9,140 (Apr 30, 2026) — essentially flat.
• · Total liabilities increased 6.1% from $1,169,622 (Jan 31, 2026) to $1,240,775 (Apr 30, 2026).
• · Accumulated deficit grew from ($1,632,570) to ($1,694,988) in the quarter.
• · Common shares outstanding remained constant at 103,580,799 shares.
• · Intangible assets, net declined from $9,727 to $7,190 due to amortization.

17-06-2026

Innovative Designs Inc. (IVDN) reported net revenue of $808,666 for Q2 FY2026, up 1.5% from $796,369 in Q2 FY2025, and net income of $106,060, a 48.1% decline from $204,188 in the prior-year quarter. For the six-month period, revenue grew 8.6% to $1,440,867 and net income rose 18.1% to $267,701. However, operating income fell sharply in Q2 due to a 42.7% surge in SG&A expenses, and cash and cash equivalents dropped 40.8% from October 2025 to $358,308.

• · Total assets increased 14.6% to $2,536,028 from $2,212,017 at October 31, 2025.
• · Accounts receivable nearly doubled to $661,375 from $344,700 at October 31, 2025.
• · Inventory grew 7.7% to $579,366 from $537,713.
• · Total current liabilities rose 51.2% to $195,848 from $129,538.
• · Long-term shareholder loans were fully repaid, dropping to $0 from $10,000.
• · Accumulated deficit improved to $(9,777,629) from $(10,045,330).
• · Cash used in operating activities was $(126,002) for the six months, compared to $(129,461) in the prior period.
• · No stock sales or share issuances occurred in the current six-month period, versus $40,000 in stock sales and $82,000 in shares for services in the prior period.
• · Depreciation expense increased to $7,646 from $3,811 for the six-month period.

17-06-2026

VITASPRING BIOMEDICAL CO. LTD. reported no revenue for the three and nine months ended October 31, 2025 and 2024, with net losses of $142,518 and $333,904 respectively for the current periods. The company's accumulated deficit increased to $5,615,407 as of October 31, 2025, while total assets rose to $16,465 from $14,378 at January 31, 2025, primarily due to higher cash and prepaid expenses. However, the company continues to rely on related-party advances and has a stockholders' deficit of $4,349,104, indicating ongoing financial challenges.

• · Revenue remained zero for all periods reported.
• · Selling, general and administrative expenses decreased to $135,733 for the three months ended October 31, 2025 from $117,927 in the prior year period, and to $303,947 for the nine months ended October 31, 2025 from $553,420 in the prior year period.
• · Provision for income tax expense was $6,785 for the three months ended October 31, 2025, down from $78,365 in the prior year period.
• · Net cash used in operating activities improved to $2,812 for the nine months ended October 31, 2025 from $12,885 in the prior year period.
• · Net cash provided by financing activities was $4,500 for the nine months ended October 31, 2025, down from $14,934 in the prior year period.
• · Cash at end of period was $1,960 as of October 31, 2025, compared to $2,062 as of October 31, 2024.
• · Stock-based compensation was zero for the nine months ended October 31, 2025, compared to $109,911 in the prior year period.
• · Equipment and vehicle, net decreased significantly from $14,106 to $6,638 due to accumulated depreciation.
• · Accounts payable and other payables increased to $609,352 as of October 31, 2025 from $494,751 as of January 31, 2025.
• · Income tax payable increased to $342,879 as of October 31, 2025 from $313,722 as of January 31, 2025.

17-06-2026

Electronic Servitor Publication Network, Inc. reported a net loss of $170,479 for the three months ended March 31, 2025, compared to a net loss of $173,068 in the same period of 2024, a slight improvement of 1.5%. Revenue dropped to $0 from $50,000 in the prior year, while operating expenses decreased 24.3% to $164,228. The company had cash of $51,176 as of March 31, 2025, down from $54,557 at year-end 2024, and continues to operate with a stockholders' deficit of $2,802,549.

• · Stock-based compensation remained flat at $139,847 in both Q1 2025 and Q1 2024.
• · Professional fees dropped sharply from $46,000 in Q1 2024 to $350 in Q1 2025.
• · General and administrative expenses decreased from $30,970 to $24,031 YoY.
• · Total current liabilities increased slightly to $2,853,725 from $2,847,474 at year-end 2024.
• · Accumulated deficit grew to $7,999,678 from $7,829,199.
• · Net cash used in operating activities improved to $3,381 from $8,470 in the prior year period.
• · The company has a note payable of $2,500,000 and loans payable of $229,630.
• · Weighted average shares outstanding increased to 52,924,668 from 51,728,001 YoY.
• · The company entered into an Asset Purchase Agreement with Phitech Management, LLC and an Agreement and Plan of Merger with Pointward Inc.